Similar articles

• Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.

  Cai Q, Costa DN, Metter CK, Goldberg K, Roehrborn CG, Cadeddu J, Pedrosa I, Meng X, Mostardeiro TR, Shah RB. Cai Q, et al. Urol Oncol. 2022 Oct;40(10):452.e1-452.e8. doi: 10.1016/j.urolonc.2022.07.012. Epub 2022 Aug 23. Urol Oncol. 2022. PMID: 36008255
• Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.

  Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S. Prendeville S, et al. J Urol. 2018 Jul;200(1):104-113. doi: 10.1016/j.juro.2018.01.081. Epub 2018 Feb 2. J Urol. 2018. PMID: 29408568
• Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology.

  Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP. Truong M, et al. J Urol. 2017 Aug;198(2):316-321. doi: 10.1016/j.juro.2017.01.077. Epub 2017 Feb 3. J Urol. 2017. PMID: 28163032
• The cribriform morphology impairs Gleason 7 prostate cancer lesion detection on multiparametric magnetic resonance imaging.

  Kazan O, Gunduz N, Kir G, Iplikci A, Dogan MB, Cecikoglu GE, Culpan M, Yildirim A. Kazan O, et al. Prostate. 2023 Mar;83(4):331-339. doi: 10.1002/pros.24465. Epub 2022 Dec 7. Prostate. 2023. PMID: 36477738 Review.
• The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

  Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, Gordetsky JB, Guo CC, Hansel DE, Hirsch MS, Huang J, Humphrey PA, Jimenez RE, Khani F, Kong Q, Kryvenko ON, Kunju LP, Lal P, Latour M, Lotan T, Maclean F, Magi-Galluzzi C, Mehra R, Menon S, Miyamoto H, Montironi R, Netto GJ, Nguyen JK, Osunkoya AO, Parwani A, Robinson BD, Rubin MA, Shah RB, So JS, Takahashi H, Tavora F, Tretiakova MS, True L, Wobker SE, Yang XJ, Zhou M, Zynger DL, Trpkov K. Epstein JI, et al. Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA. Arch Pathol Lab Med. 2021. PMID: 32589068 Review.